β-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma
✍ Scribed by Hendrik Bläker; Walter J. Hofmann; Ralf J. Rieker; Roland Penzel; Matthias Graf; Herwart F. Otto
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 275 KB
- Volume
- 25
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
✦ Synopsis
Hepatoblastoma is a rare malignant tumor of the liver that occurs in children at an average age of 2 to 3 years. Epidemiologic studies have shown an increased frequency of this tumor type in families affected by adenomatous polyposis coli. In addition to the epidemiologic data, molecular genetic studies suggest that inactivation of the APC tumor suppressor may be involved in hepatoblastoma tumorigenesis. A major function of APC is the downregulation of -catenin, a transcription-activating protein with oncogenic potential. In an ongoing immunohistochemical study of -catenin expression in sporadic cases of tumor types that are associated with adenomatous polyposis coli, we observed increased -catenin levels in the cytoplasm and in the nuclei of three investigated hepatoblastomas. Sequencing of exon 3 of the -catenin gene (CTNNB1) revealed an activating mutation in one of the tumor samples. Our data indicate for the first time that -catenin accumulation may play a role in the development of hepatoblastoma and that activating mutations of the -catenin gene may substitute biallelic APC inactivation in this tumor type.
📜 SIMILAR VOLUMES
As a signaling protein in the Wnt pathway -catenin plays a crucial role in the regulation of cellular proliferation. Recently, oncogenic -catenin mutations were described in human colorectal cancer and melanoma cell lines. Since activating mutations in the -catenin gene have similar effects on th
In this study, mutational and immunohistochemical analyses of b-catenin were performed in 30 hepatoblastomas, to assess the prevalence of alterations of the Wnt pathway with respect to clinicopathological parameters and survival. Four missense mutations of b-catenin (13.3%) were detected and there w
Recent evidence suggests that the β-catenin gene (CTNNB1) acts as an oncogene, and some human colon tumors with an intact APC gene have activating mutations in CTNNB1. In this study, mutations in the region corresponding to N-terminal phosphorylation sites (codons 1-51) of the rat Ctnnb1 gene were i